Intrinsiqs

Is Alterity Therapeutics Limited overvalued?

Alterity Therapeutics Limited (ATHE) — key valuation metrics and fundamentals.

No verdict
Price
$4.79
Fair value
Current P/E
Normal P/E
Market cap
$81.1M
Dividend yield
0.0%
Return on equity
-29.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ATHE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.